Fastly Stock Gets IBD Rating Upgrade

Blockhead
18 Dec 2024

One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Fastly (FSLY) stock cleared that benchmark Tuesday, with a jump from 80 to 84.

X
What's The EV Forecast For 2025?
See All Videos
NOW PLAYING What's The EV Forecast For 2025?

This exclusive rating from Investor's Business Daily tracks market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price behavior over the trailing 52 weeks compares to all the other stocks in our database.

Decades of market research reveals that the best stocks typically have an RS Rating north of 80 in the early stages of their moves.


Hone Your Stock-Picking Skills By Focusing On These Factors


Is Fastly Stock A Buy?

Fastly stock reclaimed its 200-day moving average in early December and has been rallying. While the stock is not near a proper buying range right now, see if it goes on to form and break out of a proper consolidation.

The computer enterprise software company posted 0% EPS growth in its most recent report. Sales increased 7%.

Fastly stock holds the No. 65 rank among its peers in the Computer Software-Enterprise industry group. Datadog (DDOG), Enfusion (ENFN) and Klaviyo (KVYO) are among the top 5 highly rated stocks within the group.

YOU MAY ALSO LIKE:

MarketSurge's Tools Can Help The Individual Investor

IBD Live: A New Tool For Daily Stock Market Analysis

Profit From Short-Term Trends With SwingTrader

How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10